Related Experiment Video
Updated: May 12, 2026

Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure
Published on: February 8, 2022
The search for paroxysmal atrial fibrillation in cryptogenic stroke: leave no stone unturned
Alexander C Flint1, Ashis H Tayal
1Kaiser Permanente, Redwood City, CA, USA. alexander.flint@gmail.com
Insights
Detecting paroxysmal atrial fibrillation (PAF) is crucial for preventing recurrent ischemic strokes. Anticoagulation therapy is beneficial for patients with PAF, similar to those with continuous atrial fibrillation.
Area of Science:
- Cardiology
- Neurology
- Stroke Prevention
Background:
- Atrial fibrillation (AF) is a significant cause of ischemic stroke, identified in up to 25% of initial strokes.
- Identifying AF as a cause of ischemic stroke is critical for implementing secondary stroke prevention strategies.
- Paroxysmal atrial fibrillation (PAF) presents diagnostic challenges due to intermittent episodes, potentially missed by short-term monitoring.
Discussion:
- Most evidence supporting anticoagulation for stroke prevention in AF patients comes from studies on continuous AF.
- Paroxysmal AF carries a stroke risk comparable to continuous AF.
- Anticoagulation appears to offer similar stroke risk reduction benefits for patients with PAF as for those with continuous AF.
Key Insights:
- Conventional monitoring may fail to detect paroxysmal atrial fibrillation (PAF).
- PAF poses a stroke risk similar to continuous atrial fibrillation.
- Anticoagulation therapy demonstrates efficacy in reducing stroke risk for patients with PAF.
Outlook:
- Further research may refine diagnostic strategies for PAF detection.
- Optimizing anticoagulation protocols for PAF patients could improve secondary stroke prevention.
- Understanding the nuances of PAF is essential for comprehensive stroke management.
Abstract:
Atrial fibrillation (AF), a well-established cause of ischemic stroke, is found in up to 25% of first strokes.(1,2) Most patients with stroke from AF will benefit from anticoagulation for secondary stroke prevention, so finding AF as a cause of ischemic stroke is critical. Many patients with AF have paroxysmal AF (PAF), in which periods of normal sinus rhythm alternate with sometimes brief episodes of AF. Conventional monitoring for AF in the hospital or for a small number of days as an outpatient may therefore miss the diagnosis of PAF. Although most of the data to support anticoagulation for stroke patients with AF come from patients with continuous AF, PAF has a similar risk of stroke when compared to continuous AF(3,4) and there appears to be a similar benefit of anticoagulation in reducing the risk of stroke in patients with PAF.(3.)
Related Concept Videos
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Acute Coronary Syndrome III: Diagnostic Studies
Hemorrhagic Stroke ll: Pathophysiology
Ischemic Stroke ll: Pathophysiology
Transient Ischemic Attack l: Introduction
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

